Indianapolis, IN, United States of America

Edward M Desimone, Iii


Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Edward M. DeSimone, III

Introduction

Edward M. DeSimone, III is a notable inventor based in Indianapolis, Indiana, recognized for his significant contributions to the field of pharmaceutical innovations. With a total of nine patents to his name, DeSimone has made substantial advancements, particularly in the storage and preparation of corticotropin compositions.

Latest Patents

Among his latest innovations, two notable patents stand out. The first is titled "Methods for Storing and Warming Purified Corticotropin Compositions." This method involves storing a sterile corticotropin composition at temperatures between 2° and 8° Celsius, subsequently warming it to a range of 18° to 26° Celsius, and then administering it in specific dosages to human subjects. Notably, the composition adheres to highly regulated standards, including the requirement of limited Vasopressin Units.

The second patent, "Kits for Preparing and Delivering Purified Corticotropin," highlights his approach to creating a sterile preparation extracted from porcine pituitary glands. This innovation outlines methods for removing larger molecular proteins to ensure the efficacy and stability of the corticotropin during storage and application.

Career Highlights

Edward has held pivotal roles in esteemed companies, including Phyton Holdings, LLC and Ani Pharmaceuticals, Inc. His extensive experience in these organizations has equipped him with the knowledge and skills necessary to develop and bring to market his groundbreaking inventions.

Collaborations

Throughout his career, DeSimone has collaborated with various professionals, including his colleagues Brian A. Bucher and Roland R. Franke. Their collective efforts and expertise have contributed to the success of the projects they have undertaken, significantly advancing the scientific community's capabilities in corticotropin research and application.

Conclusion

Edward M. DeSimone, III exemplifies the spirit of innovation within the pharmaceutical industry. His array of patents not only reflects his dedication as an inventor but also significantly impacts the treatment and management of various conditions through improved corticotropin preparation and delivery methods. As he continues to work at the forefront of pharmaceutical advancements, his contributions remain essential to the fields of medicine and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…